HealthTree Foundation Homepage Curriculum Vitae Research Projects Homepage OLD Myeloma Contact Press Multiple Myeloma Treatments Myeloma 101 Books Research Services Testimonials Testimonials-2 Myeloma Q&A Home Page TEST Janie Ruxolitinib Is Under Investigation as JAK Inhibition Strategy for Multiple Myeloma Homepage TEST Greg Myeloma FAQ Biography Privacy Policy Registration Form Becoming a Patient Resources Dr. James R. Berenson Homepage TEST FINAL Ruxolitinib Elicits Few Adverse Effects When Treating Multiple Myeloma News Ruxolitinib/Selinexor Combo Is Being Evaluated for Multiple Myeloma VJHemOnc Exploring the Potential Role of JAK Inhibitors in Multiple Myeloma Launch of Myeloma BioBank Targeted Oncology Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study Dinner with the Docs – James R. Berenson, MD – Southern California Dinner with the Docs – James R. Berenson, MD – Southern California Benefits of MRD Testing for the Treatment of Patients With Multiple Myeloma Kilee Lippincott, MHA MedPage Today American Society of Hematology Benefits of MRD Testing for the Treatment of Patients With Multiple Myeloma OncologyTube: James R. Berenson, MD Multiple Myeloma Q&A MedPage Today OncologyTube: James R. Berenson, MD HealthTree Foundation Healio Hematology & Oncology News VJ HEM/ONC HemOnc Today IMBCR & Emory University’s Big Discovery!!!